drugset / Trial / NCT03469089
Touchscreen-based Cognitive Tests in Healthy Volunteers
RandomizedCrossoverDouble-blindBasic science
Summary
This phase Ib study aims to evaluate applicability of touchscreen-based cognitive test battery for assessment of ketamine-induced schizophrenia-like cognitive deficits in healthy volunteers. Additionally, the study aims to assess whether ketamine-induced cognitive deficits are reversed by modafinil using touchscreen-based test battery for testing of cognition.
Timeline
- Start
- 2018-03-12
- Primary completion
- 2018-05-16
- Completion
- 2019-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.31 mg/kg | — |
| Subject | Ketamine | Small molecule | 0.58 mg/kg | — |
| Subject | Modafinil | Small molecule | 100 mg | — |